AKBA - Akebia Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AKBA (1517022)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
27 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-05-13
AKBAHadas Nicole R.SVP, GCS - Sale$1.26-12,016651,243-2%-$15,140
2024-05-13
AKBADahan MichelSVP, COOS - Sale$1.26-34,840672,092-5%-$43,898
2023-08-25
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$1.15-27,000668,840-4%-$31,050
2024-02-29
AKBADahan MichelSVP, COOS - Sale$1.58-8,661706,932-1%-$13,684
2024-02-29
AKBAHadas Nicole R.SVP, GCS - Sale$1.58-5,974663,259-1%-$9,439
2024-02-29
AKBAButler John P.CEO, PresS - Sale$1.58-46,5702,364,436-2%-$73,581
2024-02-29
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$1.58-7,169695,840-1%-$11,327
2024-02-27
AKBAHadas Nicole R.SVP, GCS - Sale$1.52-7,411669,233-1%-$11,265
2024-02-27
AKBADahan MichelSVP, COOS - Sale$1.52-10,744715,593-1%-$16,331
2024-02-27
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$1.52-8,367703,009-1%-$12,718
2024-02-27
AKBAButler John P.CEO, PresS - Sale$1.52-37,7332,411,006-2%-$57,354
D
2024-02-01
AKBAButler John P.CEO, PresS - Sale+OE$1.68-46,4892,448,739-2%-$78,102
D
2024-02-01
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale+OE$1.68-24,311711,376-3%-$40,842
D
2023-05-25
AKBAHadas Nicole R.SVP, GCS - Sale+OE$1.22-63,186524,344-11%-$77,270
D
2023-05-25
AKBADahan MichelSVP, COOS - Sale+OE$1.22-95,478574,037-14%-$116,760
2023-05-16
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$1.07-63,567530,487-11%-$67,890
2023-05-16
AKBASpellman David ASVP, CFO, TreasurerS - Sale$1.07-63,567446,483-12%-$67,890
2023-03-01
AKBAButler John P.CEO, PresS - Sale$0.88-91,8681,888,728-5%-$80,614
2023-03-01
AKBAHadas Nicole R.SVP, GCS - Sale$0.88-13,034287,530-4%-$11,437
2023-03-01
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$0.88-14,123594,054-2%-$12,393
2023-03-01
AKBADahan MichelSVP, COOS - Sale$0.88-20,412269,515-7%-$17,912
2023-03-01
AKBASpellman David ASVP, CFO, TreasurerS - Sale$0.88-7,210510,050-1%-$6,327
2023-02-27
AKBAButler John P.CEO, PresS - Sale$0.81-38,6321,980,596-2%-$31,416
2023-02-27
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$0.81-7,539608,177-1%-$6,131
2023-02-27
AKBADahan MichelSVP, COOS - Sale$0.81-10,090289,927-3%-$8,205
2023-02-27
AKBASpellman David ASVP, CFO, TreasurerS - Sale$0.81-7,539517,260-1%-$6,131
2023-02-27
AKBAHadas Nicole R.SVP, GCS - Sale$0.81-6,677300,564-2%-$5,430

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top